Northern Trust Corp Orgenesis Inc. Transaction History

Northern Trust Corp

$586 Billion
Q2 2024

A detailed history of Northern Trust Corp transactions in Orgenesis Inc. stock. As of the latest transaction made, Northern Trust Corp holds 40,512 shares of ORGS stock, worth $48,614. This represents 0.0% of its overall portfolio holdings.

Number of Shares

40,512

Previous 40,673 0.4%

Holding current value

$48,614

Previous $33,000 27.27%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.39 - $0.63 $62 - $101	-161 Reduced 0.4%	40,512 $24,000
Q1 2024 May 14, 2024	BUY	$0.28 - $0.9 $434 - $1,395	1,551 Added 3.96%	40,673 $33,000
Q4 2023 Feb 13, 2024	SELL	$0.44 - $0.96 $926 - $2,020	-2,105 Reduced 5.11%	39,122 $19,000
Q1 2023 May 15, 2023	BUY	$1.18 - $2.59 $5,900 - $12,950	5,000 Added 13.8%	41,227 $48,000
Q2 2022 Aug 12, 2022	SELL	$1.8 - $3.74 $4,327 - $8,990	-2,404 Reduced 6.22%	36,227 $88,000
Q3 2021 Nov 15, 2021	SELL	$4.6 - $5.44 $4,682 - $5,537	-1,018 Reduced 2.57%	38,631 $191,000
Q2 2021 Aug 13, 2021	SELL	$4.19 - $5.88 $633,393 - $888,867	-151,168 Reduced 79.22%	39,649 $201,000
Q1 2021 May 12, 2021	SELL	$4.77 - $8.08 $44,990 - $76,210	-9,432 Reduced 4.71%	190,817 $1.09 Million
Q4 2020 Feb 11, 2021	BUY	$4.4 - $5.63 $5,799 - $7,420	1,318 Added 0.66%	200,249 $901,000
Q3 2020 Nov 16, 2020	SELL	$4.75 - $5.99 $20,149 - $25,409	-4,242 Reduced 2.09%	198,931 $1 Million
Q2 2020 Aug 14, 2020	BUY	$3.6 - $7.84 $672,328 - $1.46 Million	186,758 Added 1137.73%	203,173 $1.24 Million
Q4 2019 Feb 14, 2020	BUY	$2.6 - $4.66 $6,084 - $10,904	2,340 Added 16.63%	16,415 $76,000
Q3 2019 Nov 13, 2019	SELL	$4.18 - $4.85 $4,598 - $5,335	-1,100 Reduced 7.25%	14,075 $63,000
Q1 2019 May 13, 2019	BUY	$4.28 - $5.6 $543 - $711	127 Added 0.84%	15,175 $81,000
Q4 2018 Feb 12, 2019	BUY	$3.88 - $7.46 $58,386 - $112,258	15,048 New	15,048 $70,000

Others Institutions Holding ORGS

# of Institutions

Shares Held

1.54M

Call Options Held

Put Options Held

View Full List

About Orgenesis Inc.

Ticker ORGS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,545,800
Market Cap $30.7M
Description
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, ...

More about ORGS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Orgenesis Inc. Transaction History